CD4 and neoplasm: Particularly, the authors identified the immunological differences in cell subpopulations between the core, middle, and edge of tumors, such that CD4+ naive T cells located at the core of the tumor had higher activation levels in angiogenesis and expressed more immune checkpoint molecules than those at the tumor edge.